Kaken Pharmaceutical (4521.TSE) Q1 2026 Earnings

6FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-139.29
-84.57
-29.85
24.87

Details

Expected EPS
24.8675410819656
Actual EPS
10.743128171999999
Surprise EPS
-14.12
Surprise Percent
+56.8%

Description

Kaken Pharmaceutical (4521.TSE) has reported earnings of 10.743128171999999 per share for Q1 2026.

0 Comments

Share your thoughts